Drug Shortage Report for TIMOLOL MALEATE-EX

Last updated on 2025-10-27 History
Report ID 227853
Drug Identification Number 02242275
Brand name TIMOLOL MALEATE-EX
Common or Proper name TIMOLOL MALEATE-EX
Company Name SANDOZ CANADA INCORPORATED
Market Status MARKETED
Active Ingredient(s) TIMOLOL
Strength(s) 0.25%
Dosage form(s) SOLUTION (EXTENDED RELEASE)
Route of administration OPHTHALMIC OPHTHALMIC
Packaging size 5ML
ATC code S01ED
ATC description ANTIGLAUCOMA PREPARATIONS AND MIOTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-05-13
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2025-10-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4600 RUE ARMAND-FRAPPIER
SAINT-HUBERT, QUEBEC
CANADA J3Z 1G5
Company contact information 1 800-361-3062

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v38 2025-10-27 French Compare
v37 2025-10-27 English Compare
v36 2025-10-27 English Compare
v35 2025-09-02 French Compare
v34 2025-09-02 English Compare
v33 2025-08-18 French Compare
v32 2025-08-18 English Compare
v31 2025-07-21 French Compare
v30 2025-07-21 English Compare
v29 2025-06-02 French Compare
v28 2025-06-02 English Compare
v27 2025-05-20 French Compare
v26 2025-05-20 English Compare
v25 2025-05-12 French Compare
v24 2025-05-12 English Compare
v23 2025-04-14 French Compare
v22 2025-04-14 English Compare
v21 2025-03-24 French Compare
v20 2025-03-24 English Compare
v19 2025-02-24 French Compare

Showing 1 to 20 of 38